Loading…

Reproducibility of the Johns Hopkins Hospital template for urologic cytology samples

Introduction Cytologic screening for urothelial carcinoma is fraught with low sensitivity, a high indeterminate rate, and until recently, poor standardization of terminology. The Johns Hopkins Hospital John K. Frost Cytopathology Laboratory has recently developed and published a template for reporti...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American Society of Cytopathology JASC 2014-05, Vol.3 (3), p.156-164
Main Authors: Olson, Matthew T., MD, Novak, Anna, CT(ASCP), Boonyaarunnate, Thiraphon, MD, Trotter, Jessi, CT(ASCP), Sachs, Sharon, CT(ASCP) (IAC), Kelly, Deidra, CT(ASCP), Ford, Sterling, CT(ASCP), Cornish, Toby C., MD, Toll, Adam, MD, Tatsas, Armanda D., MD, Maleki, Zahra, MD, Erozan, Yener S., MD, Rosenthal, Dorothy L., MD
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c326t-b77fea814ead197935b04f0130d47896d62f05d55841b08d681faaa5fe54818a3
cites cdi_FETCH-LOGICAL-c326t-b77fea814ead197935b04f0130d47896d62f05d55841b08d681faaa5fe54818a3
container_end_page 164
container_issue 3
container_start_page 156
container_title Journal of the American Society of Cytopathology JASC
container_volume 3
creator Olson, Matthew T., MD
Novak, Anna, CT(ASCP)
Boonyaarunnate, Thiraphon, MD
Trotter, Jessi, CT(ASCP)
Sachs, Sharon, CT(ASCP) (IAC)
Kelly, Deidra, CT(ASCP)
Ford, Sterling, CT(ASCP)
Cornish, Toby C., MD
Toll, Adam, MD
Tatsas, Armanda D., MD
Maleki, Zahra, MD
Erozan, Yener S., MD
Rosenthal, Dorothy L., MD
description Introduction Cytologic screening for urothelial carcinoma is fraught with low sensitivity, a high indeterminate rate, and until recently, poor standardization of terminology. The Johns Hopkins Hospital John K. Frost Cytopathology Laboratory has recently developed and published a template for reporting urine cytopathology; herein, we evaluate its interobserver reproducibility. Materials and methods Two sets of 100 cases each were deidentified; each set was reviewed by 5 of 10 observers in a randomized order at the direction of computerized data collection software that tracked observation time as well as observer classification of the atypia-no atypia, atypia (AUC-US), or atypia suggestive of high-grade urothelial carcinoma (AUC-H). Specific morphologic features were also recorded. Cases were grouped into low-, intermediate-, and high-agreement based on the number of observers who made the assessment. The findings were correlated against clinical outcomes. Results High agreement among observers about the presence or absence of high-grade features was possible in approximately two-thirds of indeterminate urine cases. Time and order did not factor significantly into observer propensity for identifying atypical features or favoring either AUC-US or AUC-H, and cases with high agreement about the presence of high-grade features were more likely to have a malignant follow-up. Furthermore, AUC-H diagnoses based on 2 or more high-grade features had a significantly higher malignancy risk than AUC-US diagnoses did. Conclusions AUC-H is a valid diagnostic category with specific, reproducibly identified features that portend a higher risk of malignancy than the findings of AUC-US.
doi_str_mv 10.1016/j.jasc.2014.02.003
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2229245340</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S2213294514000763</els_id><sourcerecordid>2229245340</sourcerecordid><originalsourceid>FETCH-LOGICAL-c326t-b77fea814ead197935b04f0130d47896d62f05d55841b08d681faaa5fe54818a3</originalsourceid><addsrcrecordid>eNp9kU1rFjEUhQdRbKn9Ay4kSzfvNJ_zASJIqbZSENq6DpnkxmaadzImGWH-fTO-VaQLs7kXcs6B-5yqektwTTBpzsZ6VEnXFBNeY1pjzF5Ux5QStqM9Fy__2Y-q05RGXF7fYirY6-qIESxIy_FxdXcDcwxm0W5w3uUVBYvyPaCv4X5K6DLMD-73TLPLyqMM-9mrDMiGiJYYfPjhNNJr3rYVJVW-Ib2pXlnlE5w-zZPq--eLu_PL3fW3L1fnn653mtEm74a2taA6wkEZ0rc9EwPmFhOGDW-7vjENtVgYITpOBtyZpiNWKSUsCN6RTrGT6v0ht5zwc4GU5d4lDd6rCcKSJKW0p1wwjouUHqQ6hpQiWDlHt1dxlQTLDagc5QZUbkAlprIALaZ3T_nLsAfz1_IHXxF8OAigXPnLQZRJO5g0GBdBZ2mC-3_-x2d27d3ktPIPsEIawxKnwk8SmYpB3m6Vbo0SXspsG8YeAWbym2s</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2229245340</pqid></control><display><type>article</type><title>Reproducibility of the Johns Hopkins Hospital template for urologic cytology samples</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Olson, Matthew T., MD ; Novak, Anna, CT(ASCP) ; Boonyaarunnate, Thiraphon, MD ; Trotter, Jessi, CT(ASCP) ; Sachs, Sharon, CT(ASCP) (IAC) ; Kelly, Deidra, CT(ASCP) ; Ford, Sterling, CT(ASCP) ; Cornish, Toby C., MD ; Toll, Adam, MD ; Tatsas, Armanda D., MD ; Maleki, Zahra, MD ; Erozan, Yener S., MD ; Rosenthal, Dorothy L., MD</creator><creatorcontrib>Olson, Matthew T., MD ; Novak, Anna, CT(ASCP) ; Boonyaarunnate, Thiraphon, MD ; Trotter, Jessi, CT(ASCP) ; Sachs, Sharon, CT(ASCP) (IAC) ; Kelly, Deidra, CT(ASCP) ; Ford, Sterling, CT(ASCP) ; Cornish, Toby C., MD ; Toll, Adam, MD ; Tatsas, Armanda D., MD ; Maleki, Zahra, MD ; Erozan, Yener S., MD ; Rosenthal, Dorothy L., MD</creatorcontrib><description>Introduction Cytologic screening for urothelial carcinoma is fraught with low sensitivity, a high indeterminate rate, and until recently, poor standardization of terminology. The Johns Hopkins Hospital John K. Frost Cytopathology Laboratory has recently developed and published a template for reporting urine cytopathology; herein, we evaluate its interobserver reproducibility. Materials and methods Two sets of 100 cases each were deidentified; each set was reviewed by 5 of 10 observers in a randomized order at the direction of computerized data collection software that tracked observation time as well as observer classification of the atypia-no atypia, atypia (AUC-US), or atypia suggestive of high-grade urothelial carcinoma (AUC-H). Specific morphologic features were also recorded. Cases were grouped into low-, intermediate-, and high-agreement based on the number of observers who made the assessment. The findings were correlated against clinical outcomes. Results High agreement among observers about the presence or absence of high-grade features was possible in approximately two-thirds of indeterminate urine cases. Time and order did not factor significantly into observer propensity for identifying atypical features or favoring either AUC-US or AUC-H, and cases with high agreement about the presence of high-grade features were more likely to have a malignant follow-up. Furthermore, AUC-H diagnoses based on 2 or more high-grade features had a significantly higher malignancy risk than AUC-US diagnoses did. Conclusions AUC-H is a valid diagnostic category with specific, reproducibly identified features that portend a higher risk of malignancy than the findings of AUC-US.</description><identifier>ISSN: 2213-2945</identifier><identifier>EISSN: 2213-2945</identifier><identifier>DOI: 10.1016/j.jasc.2014.02.003</identifier><identifier>PMID: 31051740</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Interobserver reproducibility ; Pathology ; The Johns Hopkins System for Reporting Urinary Cytopathology ; The Paris System for Reporting Urinary Cytopathology ; Urinary cytology ; Urothelial carcinoma</subject><ispartof>Journal of the American Society of Cytopathology JASC, 2014-05, Vol.3 (3), p.156-164</ispartof><rights>American Society of Cytopathology</rights><rights>2014 American Society of Cytopathology</rights><rights>Copyright © 2014 American Society of Cytopathology. Published by Elsevier Inc. All rights reserved.</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c326t-b77fea814ead197935b04f0130d47896d62f05d55841b08d681faaa5fe54818a3</citedby><cites>FETCH-LOGICAL-c326t-b77fea814ead197935b04f0130d47896d62f05d55841b08d681faaa5fe54818a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31051740$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Olson, Matthew T., MD</creatorcontrib><creatorcontrib>Novak, Anna, CT(ASCP)</creatorcontrib><creatorcontrib>Boonyaarunnate, Thiraphon, MD</creatorcontrib><creatorcontrib>Trotter, Jessi, CT(ASCP)</creatorcontrib><creatorcontrib>Sachs, Sharon, CT(ASCP) (IAC)</creatorcontrib><creatorcontrib>Kelly, Deidra, CT(ASCP)</creatorcontrib><creatorcontrib>Ford, Sterling, CT(ASCP)</creatorcontrib><creatorcontrib>Cornish, Toby C., MD</creatorcontrib><creatorcontrib>Toll, Adam, MD</creatorcontrib><creatorcontrib>Tatsas, Armanda D., MD</creatorcontrib><creatorcontrib>Maleki, Zahra, MD</creatorcontrib><creatorcontrib>Erozan, Yener S., MD</creatorcontrib><creatorcontrib>Rosenthal, Dorothy L., MD</creatorcontrib><title>Reproducibility of the Johns Hopkins Hospital template for urologic cytology samples</title><title>Journal of the American Society of Cytopathology JASC</title><addtitle>J Am Soc Cytopathol</addtitle><description>Introduction Cytologic screening for urothelial carcinoma is fraught with low sensitivity, a high indeterminate rate, and until recently, poor standardization of terminology. The Johns Hopkins Hospital John K. Frost Cytopathology Laboratory has recently developed and published a template for reporting urine cytopathology; herein, we evaluate its interobserver reproducibility. Materials and methods Two sets of 100 cases each were deidentified; each set was reviewed by 5 of 10 observers in a randomized order at the direction of computerized data collection software that tracked observation time as well as observer classification of the atypia-no atypia, atypia (AUC-US), or atypia suggestive of high-grade urothelial carcinoma (AUC-H). Specific morphologic features were also recorded. Cases were grouped into low-, intermediate-, and high-agreement based on the number of observers who made the assessment. The findings were correlated against clinical outcomes. Results High agreement among observers about the presence or absence of high-grade features was possible in approximately two-thirds of indeterminate urine cases. Time and order did not factor significantly into observer propensity for identifying atypical features or favoring either AUC-US or AUC-H, and cases with high agreement about the presence of high-grade features were more likely to have a malignant follow-up. Furthermore, AUC-H diagnoses based on 2 or more high-grade features had a significantly higher malignancy risk than AUC-US diagnoses did. Conclusions AUC-H is a valid diagnostic category with specific, reproducibly identified features that portend a higher risk of malignancy than the findings of AUC-US.</description><subject>Interobserver reproducibility</subject><subject>Pathology</subject><subject>The Johns Hopkins System for Reporting Urinary Cytopathology</subject><subject>The Paris System for Reporting Urinary Cytopathology</subject><subject>Urinary cytology</subject><subject>Urothelial carcinoma</subject><issn>2213-2945</issn><issn>2213-2945</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNp9kU1rFjEUhQdRbKn9Ay4kSzfvNJ_zASJIqbZSENq6DpnkxmaadzImGWH-fTO-VaQLs7kXcs6B-5yqektwTTBpzsZ6VEnXFBNeY1pjzF5Ux5QStqM9Fy__2Y-q05RGXF7fYirY6-qIESxIy_FxdXcDcwxm0W5w3uUVBYvyPaCv4X5K6DLMD-73TLPLyqMM-9mrDMiGiJYYfPjhNNJr3rYVJVW-Ib2pXlnlE5w-zZPq--eLu_PL3fW3L1fnn653mtEm74a2taA6wkEZ0rc9EwPmFhOGDW-7vjENtVgYITpOBtyZpiNWKSUsCN6RTrGT6v0ht5zwc4GU5d4lDd6rCcKSJKW0p1wwjouUHqQ6hpQiWDlHt1dxlQTLDagc5QZUbkAlprIALaZ3T_nLsAfz1_IHXxF8OAigXPnLQZRJO5g0GBdBZ2mC-3_-x2d27d3ktPIPsEIawxKnwk8SmYpB3m6Vbo0SXspsG8YeAWbym2s</recordid><startdate>201405</startdate><enddate>201405</enddate><creator>Olson, Matthew T., MD</creator><creator>Novak, Anna, CT(ASCP)</creator><creator>Boonyaarunnate, Thiraphon, MD</creator><creator>Trotter, Jessi, CT(ASCP)</creator><creator>Sachs, Sharon, CT(ASCP) (IAC)</creator><creator>Kelly, Deidra, CT(ASCP)</creator><creator>Ford, Sterling, CT(ASCP)</creator><creator>Cornish, Toby C., MD</creator><creator>Toll, Adam, MD</creator><creator>Tatsas, Armanda D., MD</creator><creator>Maleki, Zahra, MD</creator><creator>Erozan, Yener S., MD</creator><creator>Rosenthal, Dorothy L., MD</creator><general>Elsevier Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201405</creationdate><title>Reproducibility of the Johns Hopkins Hospital template for urologic cytology samples</title><author>Olson, Matthew T., MD ; Novak, Anna, CT(ASCP) ; Boonyaarunnate, Thiraphon, MD ; Trotter, Jessi, CT(ASCP) ; Sachs, Sharon, CT(ASCP) (IAC) ; Kelly, Deidra, CT(ASCP) ; Ford, Sterling, CT(ASCP) ; Cornish, Toby C., MD ; Toll, Adam, MD ; Tatsas, Armanda D., MD ; Maleki, Zahra, MD ; Erozan, Yener S., MD ; Rosenthal, Dorothy L., MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c326t-b77fea814ead197935b04f0130d47896d62f05d55841b08d681faaa5fe54818a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Interobserver reproducibility</topic><topic>Pathology</topic><topic>The Johns Hopkins System for Reporting Urinary Cytopathology</topic><topic>The Paris System for Reporting Urinary Cytopathology</topic><topic>Urinary cytology</topic><topic>Urothelial carcinoma</topic><toplevel>online_resources</toplevel><creatorcontrib>Olson, Matthew T., MD</creatorcontrib><creatorcontrib>Novak, Anna, CT(ASCP)</creatorcontrib><creatorcontrib>Boonyaarunnate, Thiraphon, MD</creatorcontrib><creatorcontrib>Trotter, Jessi, CT(ASCP)</creatorcontrib><creatorcontrib>Sachs, Sharon, CT(ASCP) (IAC)</creatorcontrib><creatorcontrib>Kelly, Deidra, CT(ASCP)</creatorcontrib><creatorcontrib>Ford, Sterling, CT(ASCP)</creatorcontrib><creatorcontrib>Cornish, Toby C., MD</creatorcontrib><creatorcontrib>Toll, Adam, MD</creatorcontrib><creatorcontrib>Tatsas, Armanda D., MD</creatorcontrib><creatorcontrib>Maleki, Zahra, MD</creatorcontrib><creatorcontrib>Erozan, Yener S., MD</creatorcontrib><creatorcontrib>Rosenthal, Dorothy L., MD</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the American Society of Cytopathology JASC</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Olson, Matthew T., MD</au><au>Novak, Anna, CT(ASCP)</au><au>Boonyaarunnate, Thiraphon, MD</au><au>Trotter, Jessi, CT(ASCP)</au><au>Sachs, Sharon, CT(ASCP) (IAC)</au><au>Kelly, Deidra, CT(ASCP)</au><au>Ford, Sterling, CT(ASCP)</au><au>Cornish, Toby C., MD</au><au>Toll, Adam, MD</au><au>Tatsas, Armanda D., MD</au><au>Maleki, Zahra, MD</au><au>Erozan, Yener S., MD</au><au>Rosenthal, Dorothy L., MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reproducibility of the Johns Hopkins Hospital template for urologic cytology samples</atitle><jtitle>Journal of the American Society of Cytopathology JASC</jtitle><addtitle>J Am Soc Cytopathol</addtitle><date>2014-05</date><risdate>2014</risdate><volume>3</volume><issue>3</issue><spage>156</spage><epage>164</epage><pages>156-164</pages><issn>2213-2945</issn><eissn>2213-2945</eissn><abstract>Introduction Cytologic screening for urothelial carcinoma is fraught with low sensitivity, a high indeterminate rate, and until recently, poor standardization of terminology. The Johns Hopkins Hospital John K. Frost Cytopathology Laboratory has recently developed and published a template for reporting urine cytopathology; herein, we evaluate its interobserver reproducibility. Materials and methods Two sets of 100 cases each were deidentified; each set was reviewed by 5 of 10 observers in a randomized order at the direction of computerized data collection software that tracked observation time as well as observer classification of the atypia-no atypia, atypia (AUC-US), or atypia suggestive of high-grade urothelial carcinoma (AUC-H). Specific morphologic features were also recorded. Cases were grouped into low-, intermediate-, and high-agreement based on the number of observers who made the assessment. The findings were correlated against clinical outcomes. Results High agreement among observers about the presence or absence of high-grade features was possible in approximately two-thirds of indeterminate urine cases. Time and order did not factor significantly into observer propensity for identifying atypical features or favoring either AUC-US or AUC-H, and cases with high agreement about the presence of high-grade features were more likely to have a malignant follow-up. Furthermore, AUC-H diagnoses based on 2 or more high-grade features had a significantly higher malignancy risk than AUC-US diagnoses did. Conclusions AUC-H is a valid diagnostic category with specific, reproducibly identified features that portend a higher risk of malignancy than the findings of AUC-US.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>31051740</pmid><doi>10.1016/j.jasc.2014.02.003</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 2213-2945
ispartof Journal of the American Society of Cytopathology JASC, 2014-05, Vol.3 (3), p.156-164
issn 2213-2945
2213-2945
language eng
recordid cdi_proquest_miscellaneous_2229245340
source ScienceDirect Freedom Collection 2022-2024
subjects Interobserver reproducibility
Pathology
The Johns Hopkins System for Reporting Urinary Cytopathology
The Paris System for Reporting Urinary Cytopathology
Urinary cytology
Urothelial carcinoma
title Reproducibility of the Johns Hopkins Hospital template for urologic cytology samples
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T06%3A47%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reproducibility%20of%20the%20Johns%20Hopkins%20Hospital%20template%20for%20urologic%20cytology%20samples&rft.jtitle=Journal%20of%20the%20American%20Society%20of%20Cytopathology%20JASC&rft.au=Olson,%20Matthew%20T.,%20MD&rft.date=2014-05&rft.volume=3&rft.issue=3&rft.spage=156&rft.epage=164&rft.pages=156-164&rft.issn=2213-2945&rft.eissn=2213-2945&rft_id=info:doi/10.1016/j.jasc.2014.02.003&rft_dat=%3Cproquest_cross%3E2229245340%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c326t-b77fea814ead197935b04f0130d47896d62f05d55841b08d681faaa5fe54818a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2229245340&rft_id=info:pmid/31051740&rfr_iscdi=true